Phase 1 Clinical Stage IV Cutaneous Melanoma AJCC v8 trials recruiting now
All Clinical Stage IV Cutaneous Melanoma AJCC v8 trials, every phase
7
Phase 1 recruiting
Other phases for Clinical Stage IV Cutaneous Melanoma AJCC v8
Phase 1 Clinical Stage IV Cutaneous Melanoma AJCC v8 trials
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
- Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
- Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
- Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.